Sakai, Japan

Fumio Nishimura

This inventor holds 1 USPTO granted patent. Top assignee: Kyowa Hakko Kogyo Kabushiki Kaisha. Active years: 1978.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Fumio Nishimura. Retrieved from https://idiyas.com/inventor/fumio-nishimura-bntk6ovw

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 1978

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Fumio Nishimura: Innovator in Analgesic Development

Introduction

Fumio Nishimura is a notable inventor based in Sakai, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of analgesics. His innovative work has led to the creation of a new derivative of benzazocine, which showcases superior analgesic properties.

Latest Patents

Nishimura holds a patent for an analgesic compound, specifically 3-(3-methyl-3-butenyl)-1, 2, 3, 4, 5, 6-hexahydro-6, 11-dimethyl-8-hydroxy-2, 6-methano-3-benzazocine. This compound is recognized for its enhanced effectiveness in pain relief, marking a significant advancement in analgesic medications. He has 1 patent to his name.

Career Highlights

Fumio Nishimura is associated with Kyowa Hakko Kogyo Kabushiki Kaisha, a prominent company in the pharmaceutical industry. His work at this organization has allowed him to focus on innovative drug development, contributing to the advancement of medical science.

Collaborations

Nishimura has collaborated with notable colleagues, including Kentaro Tamaki and Naoki Naito. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of pharmaceuticals.

Conclusion

Fumio Nishimura's contributions to analgesic development highlight his role as an influential inventor in the pharmaceutical industry. His innovative work continues to impact the field positively, paving the way for future advancements in pain management.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…